Homoeopathic Treatment of Iron Deficiency Anaemia of Reproductive Females

Therapeutic effects of Lecithinum on red blood cells and haemoglobin concentration in iron deficiency anaemia of reproductive females: A randomized, double blind placebo- controlled trial - Nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2024/06/068286

Enrollment

240

Registered

2024-06-04

Start date

Unknown

Completion date

Unknown

Last updated

2024-06-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: D509- Iron deficiency anemia, unspecified

Interventions

Intervention1: Homoeopathic Treatment with Lecithinum along with Concomitant Care: Intervention is planned as administering indicated homoeopathic medicines as decided to the case or condition. Each

dosage and repetition depending upon the individual requirement of the cases. Patients will be advised to refrain from handling the globules or from eating, drinking, smoking, or brushing teeth with

dosage and repetition will be maintained depending upon the individual requirement of the cases. All sundry items will be procured from a Good Manufacturing Practice (GMP) certified firm. Duration

Eligibility

Inclusion criteria

Inclusion criteria: 1. Reproductive age group: 18-49 years. 2. Patients suffering from iron deficiency anaemia confirmed by Hb% 7-12 gm/dl and serum ferritin level less than 30 ng/mL. 3. Only female sexes 4. Person not taking any other homoeopathic medicines for last 4 weeks. 5. Illiterate people will be interviewed by the investigators maintaining adequate privacy to fill up the scales or questionnaires. 6. Literate participant able to read and write in English, Hindi or Bengali 7. Participants providing with written informed consent.

Exclusion criteria

Exclusion criteria: 1. Patients with haemoglobin less than 7 gm/dL (severe anaemia) 2. Diagnosed case of unstable mental or physical illness or other uncontrolled systemic illness or life- threatening infections (e.g., malignancy) affecting quality of life or any vital organ failure. 3. Pregnant, puerperal and lactational women 4. Any substance abuses 5. Self-reported immune – compromised state 6. Patients who are too sick for consultation 7. Simultaneous participation of any other clinical trials 8. Undergoing homoeopathic treatment for any chronic disease within last 6 month

Design outcomes

Primary

Measure	Time frame
To observe the hemoglobin percentage through complete hemogram in each sampleTimepoint: Hemoglobin percentage at baseline and every months, till 3 months in each sample	—

Secondary

Measure	Time frame
To observe the structural change in RBC, RBC count, and to measure Fatigue Severity using Fatigue Severity Score (FSS)Timepoint: 2 years or till the sample sized achieved	—

Countries

India

Contacts

Public ContactDR RUPALI BHADURI

The Calcutta Homoeopathic Medical College and Hospital

drrupalibhaduri@gmail.com9571806989

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026